Assessment of In vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (Levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes.

Rajesh Chavan,Vineet Zope,Nilesh Chavan,Javeed Shaikh,Kiran R. Patil,Ravindra D. Yeole,Sachin Bhagwat,Mahesh Vithalbhai Patel

Assessment of In vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (Levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes.

2020

Rajesh Chavan
Vineet Zope
Nilesh Chavan
Javeed Shaikh
Kiran R. Patil
Ravindra D. Yeole
Sachin Bhagwat
Mahesh Vithalbhai Patel

WCK 771 (INN: levonadifloxacin) is a novel antibacterial agent belonging to benzoquinolizine subclass of fluoroquinolones which is under clinical development as a parenteral formulation and its pro...

Keywords:

Metabolite
Cytochrome P450
Human liver
Enzyme
In vitro
Chemistry
Inhibitory postsynaptic potential
Subclass
Biochemistry
antibacterial agent

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations